Department of Health and Human Services$1.1M obligationsEnds Dec 18, 2021
Federal contract award
75N95024F00001
FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541712 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN271201600005I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $2.8M |
| Current contract value | $2.8M |
| Potential contract value / ceiling | $3.3M |
| Start date | Jul 8, 2016 |
| Current end date | Jun 30, 2026 |
| Potential end date | Jun 30, 2026 |
| Latest award activity | Apr 17, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 17, 2025 | P00003 | $0 | SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) |
| Oct 28, 2024 | P00002 | $0 | SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) |
| Sep 12, 2024 | P00001 | $2.3M | SAHN SINGLE ASCENDING DOSE (SAD) PHASE I STUDY (4ET1103) |
| Jul 1, 2024 | 0 | $428.0K | FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.